New 'Smart Bomb' drug trial seeks to target advanced cancers
NCT ID NCT07439094
Summary
This early-stage study is testing a new drug called CKD-703 in people with advanced solid tumors, including a specific type of lung cancer. The drug is designed to target cancer cells more precisely to try to shrink tumors while potentially causing fewer side effects. The study will first check the drug's safety and then see how well it works in about 140 participants whose cancer has progressed after standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.